Apply to PRESENT

Public and private companies that have assets for out-licensing or seeking clients are invited to join China FocusTM presentation and showcase. Presenting companies will not only receive 10 minutes to present during the Planery Session, but will also receive pre-conference promotion opportunity, consultation on 1-to-1 partnering and VIP networking priority.



  1. Increase your company’s visibility and generate interest among active BD executives, investors and decision makers from top Chinese pharma and investment firms
  2. Get prepared for 1-to-1 partnering meetings with pre-conference consultation and stand out through online promotion to all attendees
  3. Get feedback from Chinese investors, frame your strategy with the growing China market
Opportunities and service for presenting companies includes: (Please check each event for available presenter services).

  • 10min for PowerPoint presentation to present during the conference
  • Dedicated presenter partnering table after you pitch
  • VIP room access, network with speakers and executives from China
  • Presentation will be webcasting to 50,000 audience
  • Company profile published on event program
  • pre-conference promotion (one Wechat Promotion to Chinese attendees, one email promotion to all attendees)
  • consultation on 1-to-1 partnering prior to the conference
I wanted express my appreciation for the opportunity to participate in ‘China Focus @BTW’ . The event was organized great, the cross section of companies both domestic US and China based companies made the conference a worthwhile event. I would also add that the level of decision maker attending was fantastic there where many CEOs , Managing Directors , and Founders all in attendance ;which are essential element when have partnering discussions. The Key addresses by the two professors were quite insightful. I hope be able to participate in future events that MyBioGate will sponsor!
Bill Farley

VP Business and Corporate Development, Sorrento Therapeutics, Inc.

The China Focus meeting leads to a significant increase in the reach of a start-up like Feldan Therapeutics by allowing the connection to Chinese VCs and pharmas. This is an invaluable experience that will contribute to our growth and that allowed us to meet potential investors based in a new market.
Vincent Ménard

Director of Strategic Development, Feldan Therapeutics

Sensus was very appreciative of the China Focus conference recently held in Boston. It was well organized and well attended offering many companies an opportunity to network with interested parties from China. It was excellent.
Joe Sardano

CEO, Sensus Healthcare

The Pitch and Match session at China Focus generated a high level of interest from investors and was a way to quickly connect with a relevant and sizeable audience. We are in due diligence with two companies as a result.
Anna Sumeray

CEO, Virometix AG

China Focus @BWB (Biotech Week Boston) provides an intimate venue for companies to meet high profile executives of large Chinese companies. The information provided is very relevant to any company wanting to learn about business in China, and small enough where you can approach any of the speakers to ask personal questions.
Stanley Kim

CEO, WinSanTor

I was really glad I had a chance to attend China Focus@BWB at Boston in 2019. It provided great opportunity to meet entrepreneurs, investors and make new friends. It is honored to present my startup company (RNP Therapeutics) in front of investors, who later on might be interested in further discussion. One-on-one meeting is extremely useful to make connection. I hope I can attend next meeting in future.
Tom Wang

Acting CFO, RNP Therapeutics

This was the first time I have participated in a China-focussed event like this, and for me it surpassed expectations. I had a number of unexpected meeting requests and some really good meetings.
Personally speaking, having the event as a virtual event makes it much easier for companies in Europe to attend, rather than having to travel to attend in person. My goals are very much driven towards forging closer links with Chinese pharma companies who are seeking new early-stage opportunities in Europe, and I certainly see China FOCUS as a great opportunity to support this. 
Ian Cox, Director

IDACO Consulting Limited

previous arrow
next arrow